(Bloomberg) -- Novo Nordisk A/S and Eli Lilly & Co. shares fell early Tuesday after US President Joe Biden demanded price cuts on their blockbuster drugs for diabetes and weight loss. Most Read from BloombergDemocrats Weigh Mid-July Vote to Formally Tap Biden as NomineeTrump Immunity Ruling Means Any Trial Before Election UnlikelyBeryl Becomes Earliest Ever Category 5 Hurricane in Atlantic‘Upflation’ Is the Latest Retail Trend Driving Up Prices for US ConsumersTrump Seeks to Toss NY Felony Convi
The S&P 500 wraps up the first half with gains of 14%, representing one of the strongest performances since the late-1990s dot-com bubble.
Nvidia has more than doubled so far this year, but the biggest S&P 500 stock winner is Super Micro, one of several big AI performers.